The Premenstrual Dysphoric Disorder Awareness and Research Act of 2026 aims to enhance research, raise awareness, and improve access to treatment for Premenstrual Dysphoric Disorder (PMDD). PMDD is a severe condition that affects a significant number of women and people assigned female at birth, causing debilitating emotional and physical symptoms. The Act seeks to address the under-diagnosis and stigma surrounding PMDD, ultimately improving the quality of life for those affected.